Hematopoietic/Lymphoid Cancer Withdrawn Phase Trials for Olanzapine (DB00334)

IndicationStatusPhase
DBCOND0030132 (Hematopoietic/Lymphoid Cancer)WithdrawnNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00737191Opioids With or Without Olanzapine in Treating Patients With Moderate to Severe Cancer PainSupportive Care